ELF Form 4: Lori Keith Receives 1,680 Restricted Stock Units
Rhea-AI Filing Summary
e.l.f. Beauty director Lori Keith received a grant of 1,680 restricted stock units (RSUs) on 08/21/2025, each converting into one share upon vesting. The Form 4 shows the acquisition was reported as a non‑derivative transaction with a reported price of $0, and the reporting person's total beneficial ownership following the grant is 22,698 shares (which includes the 1,680 RSUs). The filing identifies Lori Keith as a director and was signed by an attorney‑in‑fact on 08/25/2025.
Positive
- Director alignment via equity: Grant of 1,680 RSUs increases Lori Keith's stake, aligning her interests with shareholders
- Transparent disclosure: Form 4 filed showing transaction date 08/21/2025 and total beneficial ownership of 22,698 shares
Negative
- None.
Insights
TL;DR: A routine equity compensation grant to a director increases potential ownership but raises no immediate cash impact.
The Form 4 documents a standard grant of 1,680 RSUs to director Lori Keith on 08/21/2025, reported as a non‑derivative acquisition at a $0 price per unit, consistent with typical restricted equity awards for service. The disclosure increases the director's beneficial ownership to 22,698 shares inclusive of the RSUs. This is a routine governance disclosure that confirms alignment of a board member with shareholder interests through equity compensation and does not indicate any sale or disposition.
TL;DR: The transaction is an equity grant, not a market purchase or sale, so it is immaterial to short‑term trading volume.
The reported transaction is the grant of restricted stock units rather than an open‑market trade. The Form 4 lists the transaction date as 08/21/2025, shows 1,680 RSUs added, and reports total beneficial ownership of 22,698 shares after the grant. Because the grant is reported with a $0 price and no disposals, there is no immediate cash flow or change in float from this filing. For investors focused on insider trading flows, this filing represents a compensation issuance rather than insider selling.